MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Published:2021-03-17 Issue:8 Volume:29 Page:613-618
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Donís Sergio Piñeiro,González Alba Pérez,Alves Monica Ghislaine Oliveira,do Carmo Carvalho Bruna F.,Ferreira Camila C.P.,Almeida Janete Dias,Iruegas Elena Padín,Petronacci Cintia M. Chamorro,Peñaranda José M. Suárez,Sayáns Mario Pérez

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference29 articles.

1. DNA mismatch repair and genetic instability;Harfe;Annu Rev Genet,2000

2. Regulation of DNA repair throughout the cell cycle;Branzei;Nat Rev Mol Cell Biol,2008

3. Mammalian DNA mismatch repair;Buermeyer;Annu Rev Genet,1999

4. Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions;Cooper;Histopathology,2008

5. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck;Farnebo;DNA Repair (Amst),2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained inactivation of the Polycomb PRC1 complex induces DNA repair defects and genomic instability in epigenetic tumors;Histochemistry and Cell Biology;2024-06-18

2. Investigating Tobacco’s Impact on DNA Repair Genes and Risks in Oral Precancer and Cancer: A Comprehensive Research Study;Journal of Maxillofacial and Oral Surgery;2024-06-15

3. New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma;Oral Oncology;2023-12

4. Risk Factors of Oral Cancer: Identification and Mechanism of Prevention;Handbook of Cancer and Immunology;2023

5. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma;Frontiers in Oncology;2022-10-21